This project explores the mechanisms for how fatty acids suppress the phenotype observed in a dementia model.
Learn morePeople worldwide are taking drugs like Ozempic to lose weight. The Florey’s Dr Leigh Walker and Dr Roberta Anversa investigate the rise and impact of the drug.
Read time: 5 mins
View more
Research Fellow
Dr Juan is a research fellow in the Neurotherapeutics Group at The Florey. She studies the contribution of microplastics in Parkinson's disease.
View more
The Florey is increasing its capacity to protect the public from the fatal brain condition Creutzfeldt-Jakob disease (CJD).
Read time: 3 mins
View more
The Florey fosters partnerships with industry, government and research institutes to collaborate on ground-breaking projects and drive innovation.
View more
This project investigates how gene variants predispose to the emergence of seizures within populations of neurons (microcircuits).
Learn moreDementia researchers at the Florey are taking mRNA technology in a new direction.... to target Alzheimer's disease.
Read time: 1 min
View more
The number of people with Parkinson’s disease is growing rapidly and is expected to hit 10 million by 2030. Environmental triggers are thought to be a key factor in the dramatic rise in cases. The Florey's research into Parkinson’s disease includes identifying how to slow or prevent symptoms. Facing the challenge of Parkinson’s disease The world around us is fast changing and, in many…
Read time: 3 mins
View more
We need to change the way epilepsy is managed: Study highlights differences in quality of life.
Read time: 2 mins
View more
